7th International Conference on

Diabetes & Obesity
October 24-25, 2013 – Riga, Latvia

Organized in Collaboration between

7th International Conference on

Diabetes & Obesity
October 24-25, 2013 – Riga, Latvia

Dear Colleagues,thIt is a great pleasure to welcoming you for the 7 World Congress on Diabetes & Obesity 2013 which will
be held in Riga, Latvia on October 24-25, 2013.

Obesity has reached epidemic proportions globally, with more than 1 billion adults overweight - at least 300
million of them clinically obese - and is a major contributor to the global burden of chronic disease anddisability. The obesity epidemic is not restricted to industrialized societies; this increase is often faster indeveloping countries than in the developed world.

Often coexisting in developing countries with under-nutrition, obesity is a complex condition, with serious
social and psychological dimensions, affecting virtually all ages and socioeconomic groups.
Obesity and overweight pose also a major risk for serious diet-related chronic diseases, including type-2
diabetes, cardiovascular diseases, hypertension and stroke, and certain forms of cancer. The healthconsequences range from increased risk of premature death, to serious chronic conditions that reduce theoverall quality of life. Of special concern is the increasing incidence of child obesity.

The last data from WHO and International Obesity Task Force show us a dramatic situation concerning theWorldwide prevalence of Obesity: over 300 million adults worldwide (WHO World Health Report, 2003). The
prevalence of Obesity in USA: 39.8 million American adults; more than 57% of American adults areoverweight (CDC). One-quarter of U.S. adults are obese (BMI 30).

Prevention & Treatments Strategies: Our Priority during Riga Congress
In order to participate to slow down and stop the progression of this disease, Riga Diabetes & Obesity 2013
will discuss on the latest therapeutic innovations, the new pathways which will allow the development of
new pharmaceutical treatments but also discuss how to prevent diabetes and obesity by using naturalingredients to prevent or fight against diabetes and obesity.

Riga Diabetes & Obesity 2013 aims also to launch the discussion between the different actors involved in
the fight against obesity. It still remains that diabetes and obesity are multi-factorial problems, involving
genetic, neurological, behavioral and cultural components, and as such, a long term solution to the problem isunachievable through single sector approach. Instead an integrated strategy is required, with input and close
collaboration from all of the many different stakeholders involved - the food industry, governments andregulators, researchers, health professionals, the media, and of course consumers themselves.

Among Sessions & Hot Topics of Riga Diabetes & Obesity 2013

Overview on Diabetes and Obesity in Europe and around the Worldo Where are we now? What we expect?
o How to explain the failure to stop the epidemic of diabetes and obesity?
Cellular & Molecular Targets to for Prevention & Therapies against Diabetes & Obesity
Strategies in 2013 to Prevent and/or Treat Diabetes & Obesityo The prevention and treatment will be highlighted in term of strategies and solutionso New pharmaceutical drugs
o New drugs to increase glucose excretion in urineo Non-pharmaceutical strategies
Nutrition, Diabetes & Obesity: What we can say in 2013?
o Medicalized food as a new window to personalized medicine
o Innovations, products and nutraceuticals
Microbiota, Diabetes & Obesity: 2013
o The future of medicine to prevent diabetes and obesity will come through microbiota
Diabetes, Obesity & Biotechnologies: the Non-Invasive Strategieso Non-invasive blood glucose monitoringo Challenges to tailor insulin of tomorrow: the non-invasive insulin
o Challenges of bioartificial pancreaso Stem Cells, Diabetes & Obesities, When can we do it?
o Diabetes & Telemedecine

Looking forward welcoming you in October in Riga.

Pr Marvin Edeas – Pr Andrejs Skesters
Chairmen of the Scientific Committee

On behalf of Scientific Committee
Pr Valdis Pirags
Pr Lolita Neimane
Pr Andreas Pfeiffer

7th International Conference onDiabetes & Obesity
October 24-25, 2013 – Riga, Latvia

Scientific Program

Day 1 - October 24
7h30 Opening of Registrations
9h00 Opening Riga Diabetes & Obesity World Conference by Professor Iveta Ozolanta, Vice-Rector forSciences, Riga Stardins University
Welcome note by Scientific Committee: Pr M. Edeas, Pr V. Pirags, Pr L. Neimane, Pr A. Skesters
9h15 Diabetes & Obesity: Where is (are) the Target(s)?
Marvin Edeas, President of ISANH and Congress Chairman, Paris, FranceSession 1: Overview on Diabetes and Obesity in Europe and around the World
Chairs : Pr Marvin Edeas, Pr Valdis Pirags, Pr Andrejs Skesters
9h45 Diabetes, Obesity & Cardiovascular Risk Factors: The Latvian Example
Vilnis Dzerve, University of Latvia, Riga, Latvia
10h15 Rheumatic Disorders in Patients with Diabetes Mellitus
Badal Pal, University Hospital of South Manchester, Manchester, United Kingdom
10h45 Break & Posters Session

Session 2: Cellular & Molecular Targets for Prevention& Therapies against Diabetes & Obesity
Chairs : Pr Marvin Edeas, Pr Valdis Pirags

11h15 Obesity and Brain Rewarding System
Alfreds Janis Sipol, University of Latvia, Riga, Latvia
11h45 Modifications of Glucose Transporter Expression and Nitric Oxide Production in thePathogenesis of Diabetes Mellitus Complications
Jelizaveta Sokolovska, Faculty of Medicine, University of Latvia, Riga, Latvia
12h15 Prevalence of Overweight and Obesity in a Portuguese Community Sample of Adolescents
Joana Pereira, Riga Stradins University, Latvia
12h25 Half Polished Sorghum has Lower Human Glycemic Index and Higher Antioxidant Activity onErythocyte and Prevented Colon Cancer Development in Rats induced with Azoxymethane
CarcinogenFransiska Rungkat-Zakaria, Department of Food Science and Technology, Bogor Agricultural University,Bogor, Indonesia

12h35 Lunch Break & Posters Session

Session 3: Strategies in 2013 to Prevent and/or Treat Diabetes & Obesity
Chairs: Pr Marvin Edeas, Pr Valdis Pirags
14h00 A non-Inulinocentric View on Treatment of Type 2 Diabetes Mellitus: from Claude
Bernard Onwards
Valdis Pirags, University of Latvia, Riga, Latvia
14h30 Pathogenesis of Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS), GeneralMetabolism, Cardiovascular & Cognitive Consequences
Juris Svaza, Riga Stradins University, Riga, Latvia
15h00 Bariatric Surgery, Diabetes & Obesity: Is it an Option for Type 2 Diabetes Mellitus andObesity Treatment?
Olegs Kozlovskis, Bariatric Surgeon, Sigulda Hospital, Riga, Latvia
15h30 Break & Posters Session

Session 4: Nutrition, Diabetes & Obesity: What we can say in 2013? - Part I Chairs: Pr Lolita Neimane, Pr Andreas Pfeiffer
16h00 Foods to Improve Fatty Liver and Metabolism in Type 2 Diabetes Mellitus
Andreas Pfeiffer, Charité University, Berlin, Germany
16h30 The Regulation of Energy Metabolism Pathways through L- Carnitine Homeostasis
Maija Dambrova, Riga Stardins University, Riga, Latvia
17h00 Perception of Bitter Substance Phenylthiocarbamide (PTC) and its Associations with Nutrition
PreferenceLolita Vija Neimane, Riga Stardins University, Riga, Latvia®

17h30 A Fraxinus Excelsior L. Seed Extract, Fraxipure Improves Glucose Homeostasis in ObeseAnimals and in Elderly Overweight Subjects
Marjolaine Meyer, Innovative Platform, Nutrition & Health-Personal Care, Naturex, Avignon, France
17h45 End of the First Day
19h30 Thursday Dinner

Day 2 - October 25Session 4: Nutrition, Diabetes & Obesity: What we can say in 2013? - Part II Chairs: Pr Lolita Neimane, Pr Andreas Pfeiffer
9h00 The Effects of Natural Antioxidants on Process of Complications in Patients with Type 2 Diabetes
Nijole Savickiene, Medical Academy of Lithuanian University of Health Sciences, Kaunas, Lithuania
9h30 Diabetes and Oxidative Stress: Impact of Natural Antioxidants Consumption
Stéphanie Ros, Centre Européen d’Etude du Diabète, Strasbourg, France
9h40 Activity of Ayurvedic Herbs and Formulation in Treatment of Type 2 Diabetes: Pharmacological
Evidence and Relevance for Translational and Inter-disciplinary Research
Somit Kumar, Head Clinical Pharmacology and Interdisciplinary Research, The Ayurvedic Trust,
Coimbatore, India

10h10 Diabetes & Sugar: “The Stevia Revolution”
Stevia as antioxidant and hypoglycaemia agent
Per Bendix Jeppesen, Aarhus University, Aarhus, Denmark

10h40 Break & Posters Session

Special Topic: Microbiota, Diabetes & Obesity 201311h00 Care and Nurture of the Human Symbionts Microbiota
Diana Zandere, Pauls Stradins Clinical University Hospital, Riga, Latvia

Session 5: Diabetes, Obesity & Biotechnologies: the Non-Invasive Strategies
Chairs: Dr Séverine Sigrist, Pr Marvin Edeas
11h30 The Challenges of the Bioartificial Pancreas
Séverine Sigrist, University of Strasbourg, Strasbourg, France
12h00 Oral Administration of Insuline, Recent Advances & Perspectives
Nathalie Auberval, Institut Charles Sadron, Starsbourg, France
12h30 Implementation of E-Medicine Solutions in the Care of Patients with Diabetes Mellitus in Latvia:
EMedic Project Experience
Revita Gaisuta, Pauls Stradins University Hospital, Riga, Latvia
13h00 Lunch Break & Posters Session
14h00 Short Oral Presentations
14h30 Discussion, Award & Conclusion of Riga Diabetes & Obesity 201315h30 Network Session around Drinks & Snacks – Posters Presentation
End of Riga Diabetes & Obesity 2013

Please find the Registration Formon Website